Nephros, Inc. (NEPH)
NASDAQ: NEPH · Real-Time Price · USD
5.45
-0.29 (-5.05%)
At close: Oct 29, 2025, 4:00 PM EDT
5.48
+0.03 (0.55%)
After-hours: Oct 29, 2025, 4:18 PM EDT
Nephros Market Cap
Nephros has a market cap or net worth of $57.77 million as of October 29, 2025. Its market cap has increased by 275.15% in one year.
Market Cap
57.77M
Enterprise Value
55.53M
1-Year Change
275.15%
Ranking
Category
Stock Price
$5.45
Market Cap Chart
Since August 15, 2019, Nephros's market cap has increased from $54.10M to $57.77M, an increase of 6.79%. That is a compound annual growth rate of 1.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 60.80M | 292.26% |
| Dec 31, 2024 | 15.50M | -57.30% |
| Dec 29, 2023 | 36.30M | 205.04% |
| Dec 30, 2022 | 11.90M | -80.30% |
| Dec 31, 2021 | 60.40M | -28.61% |
| Dec 31, 2020 | 84.60M | 6.82% |
| Dec 31, 2019 | 79.20M | 46.40% |
| Aug 15, 2019 | 54.10M | - |
View and export this data all the way back to 2019. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.04B |
| Johnson & Johnson | 457.77B |
| AbbVie | 402.76B |
| UnitedHealth Group | 328.31B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 220.78B |